Desh Rakshak Aushdhalaya share price
BSE: 531521Pharmaceuticals & BiotechnologySmall Cap
Last close ₹26.90₹0.00 (0.00%)
Share price at the BSE close on 23 Oct 2026. Previous close ₹26.90.
52-week range of traded prices to 23 Oct 2026
₹22.45Low, 6 May 2026₹56.58High, 23 Oct 2025
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹15 Cr4,278th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 13 Aug 2026
- 27.8
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 29 May 2026
- 1.2
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 13 Aug 2026
- 4.7%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 13 Aug 2026
- 5.8%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 29 May 2026
- 0.21
- Volume, BSEVolume. Shares traded on the last trading day.
- 100
Results
Standalone; ₹ crore, the charts by years to March, the table by quarter.Quarterly results
Quarter to Jun 2026, against the quarter beforeFiled 13 Aug
- RevenueRevenue. The pill is the change in revenue against the quarter before: this period's figure divided by that one's, less one, in per cent.
- ₹0.83 Crdown 76.01%
- Net profitNet profit. The pill is the change in net profit against the quarter before: this period's figure divided by that one's, less one, in per cent.
- ₹0.08 Crdown 72.78%
- Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax.
- 9.7%
Revenue by year
Net profit by year, a loss in red
The years either side of a change of basis do not compare. From the year to Mar 2025, the company's revenue for that year, ₹6.27 Cr, differs from its quarters added, ₹8.54 Cr.
| ₹ crore | Sep 2024Filed 15 Nov | Dec 2024Filed 13 Feb | Mar 2025Filed 13 Jun | Jun 2025Filed 13 Aug | Sep 2025Filed 14 Nov | Dec 2025Filed 13 Feb | Mar 2026Filed 29 May | Jun 2026Filed 13 Aug |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.19 | 1.88 | 4.39 | 1.30 | 0.95 | 1.40 | 3.45 | 0.83 |
| Net profit | 0.15 | 0.12 | 0.36 | 0.10 | 0.08 | 0.09 | 0.30 | 0.08 |
| Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax. | 12.2% | 6.4% | 8.1% | 7.4% | 8.7% | 6.7% | 8.5% | 9.7% |
Standalone. The last eight quarters. The latest is shaded.
The quarters either side of a change of basis do not compare. From the quarter to Mar 2025, the company's revenue for the year to Mar 2025, ₹6.27 Cr, differs from its quarters added, ₹8.54 Cr.
Business segments
In the year to Mar 2026 the company reports one business segment, MANUFACTURERS OF AYURVEDIC AND HERBAL PRODUCT, which carries all its revenue.
Where the return came from
Yearly rates to Mar 2026, per-share figures restated for splits and bonuses.
| Over | Return a year | Earnings growth | Change in P/E | Dividend yield |
|---|---|---|---|---|
| 1 year | −10.4% | −7.5% | −3.1% | 0.0% |
| 5 years | – | +0.8% | +44.7% | – |
Return is price growth plus the average dividend yield. Change in P/E is (1 + price growth) / (1 + earnings growth) - 1, so the parts compound rather than add. Return and dividend yield are left empty where a year's dividend yield in the window cannot be measured: a dividend with no amount stated, or no price at the year end.
Peers and competitors
Pharmaceuticals, 216 listed companies, priced on 23 Oct 2026. The table lists the 8 companies closest to Desh Rakshak Aushdhalaya in market cap. 1 company in the table last traded before then: its row is priced on its last trade.
Where the company sits among the companies nearest its size
| Company | |||||||||
|---|---|---|---|---|---|---|---|---|---|
 Colinz LaboratoriesCOLINZ | 17 | 6.1 | 1.7 | 26.5 | −8.4% | +484.3% | 28.7% | 1.7% | 0.00% |
 Span DivergentSDL | 17 | – | 1.1 | – | +171.7% | – | – | −24.0% | 0.00% |
 Venmax Drugs and PharmaceuticalsVENMAX | 17 | – | – | – | +385.7% | – | – | – | 0.00% |
 Star Source Multi TradeSTARSOURCE | 16 | – | 12.3 | – | – | – | −0.5% | −3.1% | 0.00% |
| Mono PharmacareMONOPHARMA | 15 | 42.4 | 0.5 | – | −1.6% | −88.3% | 1.1% | – | 0.00% |
 Beryl DrugsBERLDRG | 13 | 20.1 | 1.3 | 8.1 | +8.3% | +169.1% | 6.4% | 3.1% | 0.00% |
 Unjha FormulationsUNJHAFOR | 12 | 26.2 | 3.2 | 14.6 | +13.0% | +386.7% | 13.5% | 15.2% | 0.00% |
 Ortin GlobalORTINGLOBE | 10 | – | 8.4 | – | −58.3% | – | −56.2% | −52.2% | 0.00% |
Market cap in ₹ crore. Growth is the last twelve months against the twelve before. A figure is left empty where it would rest on a loss or the company has under a year of results on record. ROE is the shareholders' profit over their net worth. ROCE is profit before interest and tax over the whole group's net worth plus borrowings, as in the figures at the top of the page.
Latest announcements
Routine notices left out.Share news and announcements
Sep 2026
25 Sep · Intimation Pursuant To Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
1 Sep · Disclosure Under Regulation 30 Of The Securities And Exchange Board Of India ('SEBI') (Listing Obligations And Disclosure Requirements), Regulations, 2015
Aug 2026
27 Aug · Corporate action
Desh Rakshak Aushdhalaya share price by year
Each calendar year to 2025.Desh Rakshak Aushdhalaya share price history
| Year | Close at year end | Change | Highest close | Lowest close |
|---|---|---|---|---|
| 2025 | 32.00 | +93.1% | 95.14 | 17.39 |
| 2024 | 16.57 | +150.3% | 16.57 | 6.95 |
| 2023 | 6.62 | +33.5% | 6.62 | 5.20 |
| 2022 | 4.96 | +21.0% | 4.96 | 4.30 |
| 2021 | 4.10 | −4.4% | 4.29 | 3.90 |
| 2020 | 4.29 | 0.0% | 4.29 | 4.29 |
| 2019 | 4.29 | −14.2% | 4.75 | 4.09 |
| 2018 | 5.00 | −29.9% | 6.78 | 4.79 |
| 2017 | 7.13 | −4.9% | 7.50 | 7.13 |
| 2016 | 7.50 | +17.2% | 8.40 | 6.18 |
₹ per share, adjusted for splits and bonuses since. Change is on the close at the end of the year before. 2025 is from its first session, 30 Jan 2025. 2022 is from its first session, 13 Apr 2022. 2021 is from its first session, 25 Jan 2021. 2020 is from its first session, 30 Jul 2020. 2019 is from its first session, 21 Feb 2019. 2018 is from its first session, 9 Mar 2018. 2017 is from its first session, 25 Jan 2017. The close is the year's last trade for 2023 (23 Nov 2023), 2022 (2 Dec 2022), 2020 (30 Jul 2020), 2019 (8 Nov 2019) and 2017 (19 May 2017).
Recent sessions
The last 10 trading days to 23 Oct 2026, as traded on BSE.
| Date | Open | High | Low | Close | Average price | Volume |
|---|---|---|---|---|---|---|
| 23 Oct 2026 | 26.90 | 26.90 | 26.90 | 26.90 | 26.90 | 100 |
| 1 Sep 2026 | 26.90 | 26.90 | 26.90 | 26.90 | 26.90 | 100 |
| 14 Aug 2026 | 26.90 | 26.90 | 26.90 | 26.90 | 26.90 | 100 |
| 13 Aug 2026 | 27.00 | 27.00 | 26.50 | 26.90 | 26.74 | 700 |
| 11 Aug 2026 | 25.75 | 25.75 | 25.75 | 25.75 | 25.75 | 100 |
| 6 Aug 2026 | 26.75 | 26.75 | 26.75 | 26.75 | 26.75 | 100 |
| 5 Aug 2026 | 28.05 | 28.05 | 28.05 | 28.05 | 28.05 | 100 |
| 4 Aug 2026 | 29.50 | 29.50 | 29.50 | 29.50 | 29.50 | 100 |
| 17 Jul 2026 | 31.00 | 31.00 | 31.00 | 31.00 | 31.00 | 100 |
| 15 Jul 2026 | 30.97 | 31.00 | 30.97 | 31.00 | 30.98 | 200 |
Prices in ₹ per share as traded, not adjusted.
Company details
- Legal name
- Desh Rakshak Aushdhalaya Ltd.
- BSE code
- 531521
- ISIN
- INE971E01016
- Industry
- Pharmaceuticals & Biotechnology
- Face value
- ₹10
- CIN
- L33119UR1981PLC006092
- Corporate identity number, the registrar of companies' code for it